Qi Diagnostics Limited Eyes Recognition at HKMA/HKT Global Innovation Award 2024/25
(01 Nov 2024)
Qi Diagnostics Limited is proud to be participating in the HKMA/HKT Global Innovation Award 2024/25, with hopes of being recognized for its innovative breakthroughs in the health technology sector. This prestigious award honors companies that excel in technological innovation and contributes to positioning Hong Kong as a global hub for innovation.
The HKMA/HKT Global Innovation Award covers three categories: Large Organizations, SMEs, and Rising Stars. The finalists will be announced during the HKMA Global Innovation Day on 21st October, 2024, with Ir Tony Wong, Commissioner for Digital Policy of the Hong Kong SAR Government, officiating as Guest of Honour.
Qi Diagnostics has positioned itself as a leader in non-invasive diagnostic solutions, particularly with its flagship product, the KetoAir™ Ketone Breathalyzer, and its upcoming upgrade to AI-driven data processing. These innovations offer precise health data analysis and push the boundaries of intelligent diagnostic technology.
Grover Cheung, founder of Qi Diagnostics, expressed his confidence in the company’s technological strength, stating: “We believe that the solutions we have developed at Qi Diagnostics represent a breakthrough in the market, bringing new possibilities to health technology. We look forward to the opportunity for recognition in the HKMA/HKT Global Innovation Award and hope our efforts are acknowledged by the esteemed panel.”
For Qi Diagnostics, this participation is a chance to showcase the company’s innovation capabilities, and they look forward to making an impact on the global stage.
Qi Diagnostics Limited 角逐 HKMA/HKT Global Innovation Award 2024/25，展望創新突破
（2024年11月1日）
Qi Diagnostics Limited 已參與角逐 HKMA/HKT Global Innovation Award 2024/25，作為一家在健康科技領域中不斷創新的企業，公司希望能在大會中獲得高度認可。這一獎項旨在表彰在創新科技領域中具有傑出表現的企業，推動香港作為全球創新中心的發展。
HKMA/HKT Global Innovation Award 包括大型企業、中小企業及新興企業三個類別。最終入圍名單將於 2024年10月21日 的 HKMA Global Innovation Day 啟動儀式上公布，並由香港特區政府數字政策專員 黃德偉工程師 先生擔任主禮嘉賓。
Qi Diagnostics 憑藉其創新型非侵入性診斷技術，尤其是 KetoAir™ 氣酮檢測機 及其即將升級的 AI數據處理 技術，展示了公司在全球健康科技市場中的領先地位。該技術不僅為用戶提供精確的健康數據分析，也推動了診斷技術的數據智能化發展。
張煒鋒 先生，Qi Diagnostics 創辦人，對公司的實力充滿信心：「我們深信 Qi Diagnostics 所開發的技術不僅是市場上的創新突破，也為健康科技帶來了新的可能性。我們非常期待在 HKMA/HKT Global Innovation Award 中能獲得評審團的認可。」
這次角逐對 Qi Diagnostics 而言是一次展示公司創新實力的機會，公司對此充滿期待，並希望能在創新舞台上繼續發揮影響力。
